GABRIEL HABIB to Humans
This is a "connection" page, showing publications GABRIEL HABIB has written about Humans.
Connection Strength
0.069
-
Electrocardiographic Changes in a Man With Acute Pancreatitis: A Myocardial Infarction? Tex Heart Inst J. 2021 Nov 01; 48(5).
Score: 0.016
-
Is 2015 the primetime year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker? J Am Heart Assoc. 2015 Feb 19; 4(2).
Score: 0.010
-
Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper. J Cardiovasc Pharmacol Ther. 2014 Nov; 19(6):516-25.
Score: 0.010
-
Prevention of vascular events in patients with cerebrovascular disease: efficacy and appropriate duration of antiplatelet therapy. Clin Cardiol. 2006 Jun; 29(6):244-8.
Score: 0.006
-
Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality. Clin Ther. 1997; 19 Suppl A:39-52.
Score: 0.003
-
Are calcium antagonists harmful in hypertensive patients? Distinguishing hype from reality. Chest. 1995 Jul; 108(1):3-5.
Score: 0.003
-
Current status of thrombolysis in acute myocardial infarction. Part II. Optimal utilization of thrombolysis in clinical subsets. Chest. 1995 Feb; 107(2):528-34.
Score: 0.003
-
Current status of thrombolysis in acute myocardial infarction. I. Optimal selection and delivery of a thrombolytic drug. Chest. 1995 Jan; 107(1):225-32.
Score: 0.003
-
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. J Gen Intern Med. 2014 Nov; 29(11):1475-83.
Score: 0.002
-
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. J Am Soc Hypertens. 2014 Nov; 8(11):808-19.
Score: 0.002
-
Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension. 2013 May; 61(5):977-86.
Score: 0.002
-
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
Score: 0.002
-
Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. Am J Cardiol. 2008 Nov 15; 102(10):1356-60.
Score: 0.002
-
Herpes zoster and its cardiovascular complications in the elderly--another look at a dormant virus. Cardiology. 2007; 107(1):63-7.
Score: 0.001
-
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005 Apr 06; 293(13):1595-608.
Score: 0.001
-
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. J Clin Hypertens (Greenwich). 2004 Mar; 6(3):116-25.
Score: 0.001
-
Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 1999 Apr 06; 99(13):1671-7.
Score: 0.001
-
More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Circulation. 1995 Jun 01; 91(11):2725-32.
Score: 0.001
-
Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning. Am Heart J. 1994 May; 127(5):1241-50.
Score: 0.001
-
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 1987 Jan; 79(1):170-4.
Score: 0.000